Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Clinical trial NCT02808143 · COMPLETED

Trial details

NCT number: NCT02808143
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Bladder Carcinoma Stage 0a Bladder Urothelial Carcinoma Stage 0is Bladder Urothelial Carcinoma Stage I Bladder Cancer

Start date: 2017-02-10
Primary completion: 2020-05-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.